Ceapro, Inc. (OTC: CRPOF) is a Canadian biotechnology company with headquarters in Edmonton, Alberta. Through the use of proprietary technology and renewable and sustainable resources, Ceapro is focused on becoming a global leader in developing and commercializing functionally active ingredients for human and animal health markets. The company has already achieved a reputation as an innovative formulator and advanced processor of unique natural-based products supported by strong science and clinical evidence. For more information, visit the company’s website at www.ceapro.com.